Group sequential testing for cluster randomized trials with time-to-event endpoint

被引:0
作者
Li, Jianghao [1 ]
Jung, Sin-Ho [1 ]
机构
[1] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC 27705 USA
关键词
alpha spending function; dependent increment; expected sample size; intracluster correlation coefficient; log-rank test; variable cluster size; MAXIMUM DURATION; LOGRANK TESTS; DESIGN;
D O I
10.1111/biom.13498
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We propose group sequential methods for cluster randomized trials (CRTs) with time-to-event endpoint. The alpha spending function approach is used for sequential data monitoring. The key to this approach is determining the joint distribution of test statistics and the information fraction at the time of interim analysis. We prove that the sequentially computed log-rank statistics in CRTs do not have independent increment property. We also propose an information fraction for group sequential trials with clustered survival data and a corresponding sample size determination approach. Extensive simulation studies are conducted to evaluate the performance of our proposed testing procedure using some existing alpha spending functions in terms of expected sample size and maximal sample size. Real study examples are taken to demonstrate our method.
引用
收藏
页码:1353 / 1364
页数:12
相关论文
共 50 条
[21]   Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints [J].
Beisel, Christina ;
Benner, Axel ;
Kunz, Christina ;
Kopp-Schneider, Annette .
BIOMETRICAL JOURNAL, 2017, 59 (03) :511-530
[22]   A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome [J].
Patrick Royston ;
Mahesh K. B. Parmar .
Trials, 21
[23]   Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials [J].
Bellera, Carine A. ;
Pulido, Marina ;
Gourgou, Sophie ;
Collette, Laurence ;
Doussau, Adelaide ;
Kramar, Andrew ;
Dabakuyo, Tienhan Sandrine ;
Ouali, Monia ;
Auperin, Anne ;
Filleron, Thomas ;
Fortpied, Catherine ;
Le Tourneau, Christophe ;
Paoletti, Xavier ;
Mauer, Murielle ;
Mathoulin-Pelissier, Simone ;
Bonnetain, Franck .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (04) :769-781
[24]   Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology [J].
Horiguchi, Miki ;
Hassett, Michael J. ;
Uno, Hajime .
CLINICAL TRIALS, 2020, 17 (06) :597-606
[25]   Non-inferiority trials with time-to-event data: clarifying the impact of censoring [J].
Choi, Jaeun ;
Xue, Xiaonan ;
Kim, Mimi .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024, 34 (02) :222-239
[26]   Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time [J].
Phadnis, Milind A. ;
Mayo, Matthew S. .
JOURNAL OF APPLIED STATISTICS, 2021, 48 (06) :1009-1032
[27]   Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials? [J].
A'Hern, Roger P. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) :3474-+
[28]   Group sequential methods for interim monitoring of randomized clinical trials with time-lagged outcome [J].
Tsiatis, Anastasios A. ;
Davidian, Marie .
STATISTICS IN MEDICINE, 2022, 41 (28) :5517-5536
[29]   Hierarchical testing of multiple endpoints in group-sequential trials [J].
Glimm, Ekkehard ;
Maurer, Willi ;
Bretz, Frank .
STATISTICS IN MEDICINE, 2010, 29 (02) :219-228
[30]   Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance [J].
Li, Huiling ;
Wang, Jianming ;
Luo, Xiaolong ;
Grechko, Janis ;
Jennison, Christopher .
BIOMETRICAL JOURNAL, 2018, 60 (05) :893-902